Focusing on steady progress rather than immediate results helps set realistic expectations
(Lilly Investors) Lipid Profile Improvement: Studies indicate favorable effects on lipid parameters, contributing to overall metabolic health
Widely available
However, the GLP-1 receptor/GIP receptor/GCGR triple agonist retatrutide showed strong glucose-lowering and weight-lowering efficacy (HbA 1c reduction of 22.4 mmol/mol [2.01%] at 24 weeks and body weight reduction of 13.9% at 36 weeks, placebo subtracted) during a Phase 2 trial in overweight/obese individuals with type 2 diabetes [61]
Hypersensitivity Reactions: Some people may experience allergic or hypersensitivity reactions to Ondansetron, which can manifest as rash, itching, swelling of the face, lips, tongue, or throat (angioedema), difficulty breathing, or other symptoms